100
Participants
Start Date
April 1, 2026
Primary Completion Date
May 1, 2031
Study Completion Date
May 1, 2032
Either newly diagnosed with a RD requiring initiation of therapy OR treatment change at the time of inclusion
During the first year, data related to demographics, lifestyle, laboratory and physical examinations will be collected at baseline, at month 3, at month 12 and in case of unscheduled visit. Questionnaires and standardised voice collection will be collected (optionally) at different time points using the Colive web app. Physical activity and sleep quality will be optionally monitored via a smartwatch that will be provided to interested participants. Biological sample(s) and imaging data will be collected at different time points (baseline; 3 months; 12 months; unscheduled visit). A long-term follow-up (starting from month 12 and up to 4 years after month 12) is foreseen in this study. During the long-term follow-up medical data are collected on a yearly basis, and questionnaires are collected every 6 months.
FNR (Luxembourg National Research Fund)
UNKNOWN
Hôpitaux Robert Schuman Luxembourg
UNKNOWN
University of Luxembourg
OTHER
Luxembourg Institute of Health
OTHER_GOV